Citadel Advisors - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$933,541
-81.5%
171,292
-77.2%
0.00%
-100.0%
Q2 2023$5,036,002
-32.3%
750,522
-10.9%
0.00%
-50.0%
Q1 2023$7,438,418
+61.1%
842,403
+39.4%
0.00%
+100.0%
Q4 2022$4,616,684
-27.4%
604,278
-32.3%
0.00%0.0%
Q3 2022$6,358,000
+66.8%
893,015
+89.6%
0.00%0.0%
Q2 2022$3,811,000
-13.4%
471,069
+48.6%
0.00%0.0%
Q1 2022$4,399,000
-28.3%
316,971
+45.0%
0.00%0.0%
Q4 2021$6,134,000
-31.4%
218,620
-16.8%
0.00%
-50.0%
Q3 2021$8,937,000
-31.9%
262,916
-18.1%
0.00%
-33.3%
Q2 2021$13,120,000
-60.8%
321,103
-61.4%
0.00%
-66.7%
Q1 2021$33,476,000
+366.0%
831,493
+584.4%
0.01%
+350.0%
Q4 2020$7,184,000
+67.0%
121,492
+37.4%
0.00%
+100.0%
Q3 2020$4,302,000
-14.6%
88,453
-15.1%
0.00%
-50.0%
Q2 2020$5,039,000
+154.5%
104,140
+46.1%
0.00%
Q1 2020$1,980,000
-23.7%
71,277
-17.8%
0.00%
-100.0%
Q4 2019$2,595,000
-41.4%
86,704
-39.5%
0.00%
-50.0%
Q3 2019$4,431,000
-60.9%
143,383
-38.8%
0.00%
-60.0%
Q2 2019$11,320,000234,3710.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders